Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Sponsors › Genomics: Clinical Implementation › Veracyte Genomic Classifier Test for Lung Disease Validated in Clinical Study

Veracyte Genomic Classifier Test for Lung Disease Validated in Clinical Study

Apr 02, 2019
|
staff reporter

NEW YORK (GenomeWeb) – A new study by Veracyte and collaborators demonstrates that the company’s Envisia genomic test can improve the diagnosis of patients being evaluated for interstitial lung disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  2. BD, CerTest Biotec Get CE-IVD Mark for Combination COVID-19, Influenza, RSV Test on BD Max

  3. Thermo Fisher Scientific Continues to See Strong Demand for Pandemic-Related Products and Services

    Premium

  4. FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

  5. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.